Treatment and outcome in non-Hodgkin's lymphoma patients with and without prevalent diabetes mellitus in a population-based cancer registry

2011 ◽  
Vol 2 (4) ◽  
pp. 239-245 ◽  
Author(s):  
T.T.W. van Herpt ◽  
S.A.M. van de Schans ◽  
H.R. Haak ◽  
D.J. van Spronsen ◽  
M.W. Dercksen ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Cancer Registry ◽  
Hodgkin’S Lymphoma ◽  
Population Based ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma

scholarly journals International Prognostic Index for aggressive non-Hodgkin's lymphoma is valid for all malignancy grades

Blood ◽  
1995 ◽  
Vol 86 (4) ◽  
pp. 1460-1463 ◽  
Author(s):  
J Hermans ◽  
AD Krol ◽  
K van Groningen ◽  
PM Kluin ◽  
JC Kluin-Nelemans ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Hodgkin’S Lymphoma ◽  
Performance Status ◽  
International Prognostic Index ◽  
Prognostic Index ◽  
Population Based ◽  
Hodgkin's Lymphoma ◽  
Intermediate Grade ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma

An International Prognostic Index (IPI) for patients with aggressive non-Hodgkin's lymphoma (NHL) has recently been published. The IPI is based on pretreatment clinical characteristics and developed on clinical trial patients, classified as intermediate grade according to the Working Formulation (WF). We applied this IPI in a population-based registry of NHL patients. This registry does not have the restrictions that usually hold for patients in clinical trials, eg, with respect to age and performance status. Moreover, it covers all the three WF classes (low, intermediate, and high). The IPI turned out to be of prognostic value for response rate and survival in our unselected cohort of 744 patients, as well. In each of the three WF classes separately, the four IPI classes showed going from low to high substantially decreasing response rates and survival percentages. For our cohort of WF intermediate grade patients 5-year survival levels were lower in all four IPI classes (59%, 34%, 14%, and 10%, respectively), probably reflecting the selection of clinical trial patients in the original study (73%, 51%, 43%, and 26%).

scholarly journals Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden

1999 ◽  
Vol 80 (5) ◽  
pp. 641-645 ◽  
Author(s):  
Johanna Adami ◽  
Gloria Gridley ◽  
Olof Nyr�n ◽  
Mustafa Dosemeci ◽  
Martha Linet ◽  
...  
Keyword(s):  
Cohort Study ◽  
Hodgkin’S Lymphoma ◽  
Population Based ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma

Association of VEGFA gene polymorphisms with susceptibility to non-Hodgkin's lymphoma: Evidences from population-based and in silico studies

Gene Reports ◽  
2020 ◽  
Vol 20 ◽  
pp. 100696 ◽  
Author(s):  
Mohammad Ali Mashhadi ◽  
Narges Arbabi ◽  
Saman Sargazi ◽  
Fatemeh Kazemi-Lomedasht ◽  
Danial Jahantigh ◽  
...  
Keyword(s):  
In Silico ◽  
Gene Polymorphisms ◽  
Hodgkin’S Lymphoma ◽  
Population Based ◽  
Hodgkin's Lymphoma ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
In Silico Studies ◽  
Vegfa Gene

scholarly journals Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study

2006 ◽  
Vol 17 (8) ◽  
pp. 1283-1289 ◽  
Author(s):  
T. Battaglioli ◽  
G. Gorini ◽  
A. Seniori Costantini ◽  
P. Crosignani ◽  
L. Miligi ◽  
...  
Keyword(s):  
Alcohol Consumption ◽  
Cigarette Smoking ◽  
Hodgkin’S Lymphoma ◽  
Population Based ◽  
Hodgkin's Lymphoma ◽  
Population Based Study ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma

Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: a population-based case-control study

2005 ◽  
Vol 128 (5) ◽  
pp. 610-615 ◽  
Author(s):  
Brian C.-H. Chiu ◽  
Carol Kolar ◽  
Susan M. Gapstur ◽  
Terence Lawson ◽  
James R. Anderson ◽  
...  
Keyword(s):  
Hodgkin’S Lymphoma ◽  
Case Control Study ◽  
Population Based ◽  
Case Control ◽  
Hodgkin's Lymphoma ◽  
Gst Polymorphisms ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma ◽  
Control Study

Incidence and survival of gastric non-Hodgkin's lymphoma: A population-based study from the Association of the French Cancer Registries (FRANCIM)

2009 ◽  
Vol 48 (7) ◽  
pp. 977-983 ◽  
Author(s):  
Arlette Danzon ◽  
Aurélien. Belot ◽  
Marc Maynadié ◽  
Laurent Remontet ◽  
Anne Claire Gossart Dupont ◽  
...  
Keyword(s):  
Hodgkin’S Lymphoma ◽  
Cancer Registries ◽  
Population Based ◽  
Hodgkin's Lymphoma ◽  
Population Based Study ◽  
Non Hodgkin’S Lymphoma ◽  
Non Hodgkin's Lymphoma
Sign in / Sign up

Export Citation Format

Share Document